Elicio Therapeutics Inc (ELTX)
8.86
0.00 (0.00%)
USD |
NASDAQ |
May 23, 13:09
Elicio Therapeutics Total Liabilities (Quarterly): 19.61M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 19.61M |
December 31, 2023 | 15.77M |
September 30, 2023 | 17.70M |
Date | Value |
---|---|
June 30, 2023 | 14.06M |
December 31, 2022 | 124.81M |
March 31, 2021 | 73.99M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
14.06M
Minimum
Jun 2023
124.81M
Maximum
Dec 2022
44.32M
Average
18.66M
Median
Total Liabilities (Quarterly) Benchmarks
Immuneering Corp | 9.260M |
Outlook Therapeutics Inc | 193.26M |
Amylyx Pharmaceuticals Inc | 93.02M |
NovaBay Pharmaceuticals Inc | 5.197M |
Palatin Technologies Inc | 9.827M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 24.48M |
Shareholders Equity (Quarterly) | 4.87M |